Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 12 October 2010
Vol. 3, Issue 143, p. pt1
[DOI: 10.1126/scisignal.3143pt1]

PRESENTATIONS

Hormone Resistance at the Clinical Level

Ze'ev Hochberg*

Division of Pediatric Endocrinology, Meyer Children’s Hospital, Rambam Medical Center, and Rappaport Family Faculty of Medicine and Research Institute, Technion–Israel Institute of Technology, Haifa, Israel.

A presentation from the third NICHe Conference, "New Inroads to Child Health—Child Health and Signal Transduction," Varberg, Sweden, 21 to 23 May 2010.

Abstract: This presentation introduces clinical aspects of hormone resistance through a number of case studies that illustrate how molecular defects at various steps in hormone production, signaling, or responsiveness can produce disease in humans. The presentation also shows how careful phenotyping of such patients has triggered decades of translational research.

* Presenter and corresponding author. E-mail, z_hochberg{at}rambam.health.gov.il

Citation: Z. Hochberg, Hormone Resistance at the Clinical Level. Sci. Signal. 3, pt1 (2010).

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease.
A. Tomaschitz, E. Ritz, B. Pieske, A. Fahrleitner-Pammer, K. Kienreich, J. H. Horina, C. Drechsler, W. Marz, M. Ofner, T. R. Pieber, et al. (2012)
Cardiovasc Res 94, 10-19
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882